11th Invitation to Manufacturers of Reproductive Health Medicines to submit and Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines
The lack of prequalified reproductive health medicines is of great concern to WHO and to partner organizations working to improve reproductive health.